Live from the NIH registry
Studies recruiting near Lafayette right now
Top 25 of 63 recruiting studies, sorted by proximity — each links to its official registry page
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Sparrow Pharmaceuticals
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: NRG Oncology
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 2 Clinical Trial of CartiLife® in the United States
Articular Cartilage Defect, Articular Cartilage Degeneration
Phase 2
Interventional 25 participants sought
Lafayette General Health — Lafayette, Louisiana (1.3 mi)
· Sponsor: Biosolution Co., Ltd.
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: GlaxoSmithKline
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Peripheral Vascular Diseases
N/A
Observational 5,000 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Boston Scientific Corporation
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Care Access - New Iberia — New Iberia, Louisiana (19.1 mi)
· Sponsor: Eli Lilly and Company
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pfizer
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Prostatic Neoplasms
Phase 2
Interventional 100 participants sought
Southern Urology LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 460 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Influenza
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Hoffmann-La Roche
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's Disease, Obesity or Overweight
Phase 3
Interventional 290 participants sought
Care Access - New Iberia — New Iberia, Louisiana (19.1 mi)
· Sponsor: Eli Lilly and Company
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
Benign Prostatic Hyperplasia
N/A
Interventional 215 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Rivermark Medical
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 220 participants sought
Southern Urology LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Alnylam Pharmaceuticals
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Cardiovascular Institute of the South - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 750 participants sought
GSK Investigational Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: GlaxoSmithKline
A Study of BLB-201 RSV Vaccine in Infants and Children
Respiratory Syncytial Virus Infections
Phase 1, Phase 2
Interventional 137 participants sought
Velocity Clinical Research - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Blue Lake Biotechnology Inc.
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Phase 3
Interventional 400 participants sought
Velocity Clinical Research — Lafayette, Louisiana (1.3 mi)
· Sponsor: Novartis Pharmaceuticals
Galleri® in the Medicare Population.
Cancer
N/A
Interventional 50,000 participants sought
Ochsner Health Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: GRAIL, Inc.
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Asthma
Phase 2
Interventional 69 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca